Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 20 Issue: 8, September 2020

Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer

Volume:20   Issue: 8
Pp: 559-572
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy* and Piyong Sola
DOI: 10.2174/1568009620666200506110850
Published on: 06 May, 2020

Strategic Combination Therapies for Ovarian Cancer

Volume:20   Issue: 8
Pp: 573-585
Xinran Li, Angel S.N. Ng, Victor C.Y. Mak, Karen K.L. Chan, Annie N.Y. Cheung and Lydia W.T. Cheung*
DOI: 10.2174/1568009620666200511084007
Published on: 10 May, 2020

Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer

Volume:20   Issue: 8
Pp: 586-602
Manzoor A. Mir*, Hina Qayoom, Umar Mehraj, Safura Nisar, Basharat Bhat and Nissar A. Wani*
DOI: 10.2174/1570163817666200518081955
Published on: 17 May, 2020

Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer

Volume:20   Issue: 8
Pp: 603-615
Ali Sartaj, Sanjula Baboota and Javed Ali*
DOI: 10.2174/1568009620666200331124113
Published on: 31 March, 2020

VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways

Volume:20   Issue: 8
Pp: 616-623
Jing-Yi Sun, Ya-Jun Hou, Hai-Juan Cui, Cheng Zhang, Ming-Feng Yang, Feng-Ze Wang, Zheng Sun, Cun-Dong Fan*, Bao-Liang Sun* and Jin Rok Oh*
DOI: 10.2174/1568009620666200414150353
Published on: 14 April, 2020

Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway

Volume:20   Issue: 8
Pp: 624-637
Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu and Bin Yi*
DOI: 10.2174/1568009620666200424145122
Published on: 24 April, 2020

Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients

Volume:20   Issue: 8
Pp: 638-645
Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Sherief Abd-Elsalam* and Marwa A. Suliman
DOI: 10.2174/1568009620666200511084731
Published on: 10 May, 2020